Basecamp Wealth Advisors »

Lexeo Therapeutics shares owned by Basecamp Wealth Advisors

Quarter-by-quarter ownership of Lexeo Therapeutics (LXEO) shares owned by Basecamp Wealth Advisors from 13F filings

Historical chart of Basecamp Wealth Advisors investment in Lexeo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lexeo Therapeutics held by Basecamp Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexeo Therapeutics by Basecamp Wealth Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $165 29 5.72
2025-12-31 $1.1k 113 9.93

More positions owned by Basecamp Wealth Advisors

Vanguard Index Fds Vanguard Total Stk Mkt Etf Total Stk Mkt (VTI)
Vanguard Intl Equity Index Fds Allwrld Ex Us Allwrld Ex Us (VEU)
Microsoft Corporation (MSFT)
Vanguard Intl Equity Index Fds Tt Wrld St Etf Tt Wrld St Etf (VT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Eli Lilly & Co. (LLY)
Vanguard Intl Equity Index Fds Ftse Emr Mkt Etf Ftse Emr Mkt Etf (VWO)
Amazon (AMZN)
Alphabet Inc Cap Stk Cl A Cap Stk Cl A (GOOGL)
Sprott Physical Gold Trust Unit Isin #ca85207h1047 Sedol #byvw239 Physical Gold Tr (PHYS)
Alphabet Inc Cap Stk Cl C Cap Stk Cl C (GOOG)
Vanguard Total International Stock Index Fund Vg Tl Intl Stk F (VXUS)
Ishares Russell 3000 Etf Russell 3000 Etf (IWV)
Ishares Russell 1000 Index Fund Rus 1000 Etf (IWB)

View all positions for Basecamp Wealth Advisors

Top funds holding Lexeo Therapeutics

Paradigm Biocapital Advisors
BlackRock
Affinity Asset Advisors
RA Capital Management
Henderson Group
Vestal Point Capital
Frazier Life Sciences Management
Citadel Advisors
OrbiMed Advisors
State Street Corporation
Vanguard Capital Management
Woodline Partners
Goldman Sachs Group
venBio Select Advisor
Point72 Asset Management

View all funds holding Lexeo Therapeutics